VP, Asset Lead UTUC

Skip to main content VP, Asset Lead UTUC Tyra Biosciences Carlsbad, CA Apply VP, Asset Lead UTUC Tyra Biosciences Carlsbad, CA 2 weeks ago 51 applicants See who Tyra Biosciences has hired for this role Apply Save Report this job Tyra Biosciences, Inc. is seeking a highly motivated VP, Asset Lead to make impactful contributions to oncology drug development projects targeting disease areas with high unmet medical need. The successful candidate will be highly organized, self-motivated, and thrive in a dynamic, cross-functional start-up environment.This position requires broad knowledge and experience across the clinical development spectrum, specifically late-stage development. This individual is the matrix leader with overall, end-to-end accountability for a drug's development, from late-stage clinical trials through registration, launch, and life cycle management. At the P3 stage, the VP, Asset Lead will focus on generating integrated evidence for regulatory submission, optimizing commercial strategy, and ensuring cross-functional alignment to maximize the asset's value.Reporting in the COO candidates must have experience optimizing commercial strategy and ensuring cross-functional alignment to maximize the asset's value. This includes Commercialization Prep (see below).Job ResponsibilitiesStrategic Leadership: Develops and executes the comprehensive Global Asset Strategy (GAS) and Phase 3 clinical development strategy, ensuring alignment with commercial and regulatory goals.Matrix Team Management: Chairs the Asset Strategy Team (AST), guiding cross-functional teams (Clinical, Regulatory, Commercial, CMC, Supply Chain) to deliver on milestones.Governance and Decision Making: Acts as the primary point of contact for senior management and governance bodies, providing data-driven recommendations (Go/No-Go decisions) and mitigating high-impact risks.Budget and Resource Management: Oversees the asset budget, ensuring the program is adequately resourced and aligned with Portfolio Committee priorities.Regulatory/External Engagement: Represents the program at key regulatory meetings, Advisory Boards, and in interactions with corporate partners.Commercialization Prep: Partners with Commercial teams to ensure market readiness, including developing the product value proposition, label strategy, and lifecycle management plan.Minimum RequirementsAdvanced Degree in scientific/life-sciences field with a Master’s, PharmD, Ph.D., MD or MBA degree highly preferred.Large, global, late-stage Oncology Drug Development (P3) experience required. Experience with urothelial cancers a plus12+ years of experience in the pharmaceutical/biotech industry, with a focus on drug development, clinical operations, or commercialization.8+ years experience leading cross-functional or matrixed teams, with a track record of driving decision-making without direct reporting authority.Strong understanding of P3 clinical trial design, global regulatory requirements (e.g., FDA/EMA), and commercialization strategies.Prior experience working in a small, start-up biotech work environment preferred.Ability to synthesize complex data into a cohesive, long-term plan.Expert in building consensus across diverse stakeholders.Proactively identifies risks and develops mitigation strategies.Excellent written and oral communication skillsStrong analytical and strategic abilityAbility to work independently and to multi-task large...